Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? (Q26776432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

0 references

1 reference

Chandra Mohan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

Shervin Assassi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

2015

0 references

published in

The BMJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

volume

351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

page(s)

h5079

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

Association of the autoimmune disease scleroderma with an immunologic response to cancer

13 May 2020

cites work

1 reference

12 December 2020

Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus

1 reference

12 December 2020

Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

1 reference

12 December 2020

Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment

1 reference

12 December 2020

Interstitial lung disease in antisynthetase syndrome without clinical myositis

1 reference

12 December 2020

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

1 reference

12 December 2020

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

1 reference

12 December 2020

Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

12 December 2020

Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis

1 reference

12 December 2020

Antinuclear antibody-negative systemic sclerosis

1 reference

12 December 2020

A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.

1 reference

12 December 2020

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

1 reference

12 December 2020

Pharmacogenomics and translational simulations to bridge indications for an anti-interferon-α receptor antibody

1 reference

12 December 2020

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage

1 reference

12 December 2020

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

1 reference

12 December 2020

The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

1 reference

12 December 2020

Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study

1 reference

12 December 2020

A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis

1 reference

12 December 2020

Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis.

1 reference

12 December 2020

Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects

1 reference

12 December 2020

Classification, diagnosis, and management of idiopathic inflammatory myopathies

1 reference

12 December 2020

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

12 December 2020

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

1 reference

12 December 2020

Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

1 reference

12 December 2020

Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

1 reference

12 December 2020

The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis

1 reference

12 December 2020

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

12 December 2020

Biomarkers of rheumatoid arthritis: recent progress

1 reference

12 December 2020

Antibody to signal recognition particle in polymyositis

1 reference

12 December 2020

Antinuclear antibody testing. A study of clinical utility

1 reference

12 December 2020

Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression

1 reference

12 December 2020

Clinical and genetic factors predictive of mortality in early systemic sclerosis

1 reference

12 December 2020

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

1 reference

12 December 2020

The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.

1 reference

12 December 2020

Systemic and cell type-specific gene expression patterns in scleroderma skin

1 reference

12 December 2020

Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.

1 reference

12 December 2020

The role of RANK ligand/osteoprotegerin in rheumatoid arthritis

1 reference

12 December 2020

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis

1 reference

12 December 2020

Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis

1 reference

12 December 2020

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group

1 reference

12 December 2020

Delay in the diagnosis of SLE: the importance of arthritis/arthralgia as the initial symptom

1 reference

12 December 2020

Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials

1 reference

12 December 2020

Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden

1 reference

12 December 2020

C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study

1 reference

12 December 2020

The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus

1 reference

12 December 2020

An ELISA for IgA-IgG and IgM-RF measurement. II. RF in several disease and control groups and under gold therapy in RA

1 reference

12 December 2020

Prevention of relapses in systemic lupus erythematosus

1 reference

12 December 2020

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction

1 reference

12 December 2020

Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging,

1 reference

12 December 2020

Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up

1 reference

12 December 2020

Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up

1 reference

12 December 2020

Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study

1 reference

12 December 2020

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.

1 reference

12 December 2020

Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: a literature review

1 reference

12 December 2020

Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis

1 reference

12 December 2020

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

12 December 2020

HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis

1 reference

12 December 2020

Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity

1 reference

12 December 2020

Correlation between levels of DNA antibodies and clinical disease activity in SLE.

1 reference

12 December 2020

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

12 December 2020

Systemic sclerosis and lupus: points in an interferon-mediated continuum

1 reference

12 December 2020

The clinical features, diagnosis and classification of dermatomyositis.

1 reference

12 December 2020

The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis

1 reference

12 December 2020

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

1 reference

12 December 2020

Proteomic biomarkers for autoimmune disease

1 reference

12 December 2020

High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk

1 reference

12 December 2020

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

1 reference

12 December 2020

Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study

1 reference

12 December 2020

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

1 reference

12 December 2020

Prediction of pulmonary complications and long-term survival in systemic sclerosis

1 reference

12 December 2020

Editorial: the power of a modular approach to transcriptional analysis.

1 reference

12 December 2020

MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis

1 reference

12 December 2020

Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review

1 reference

12 December 2020

Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients

1 reference

12 December 2020

Autoantibodies in systemic sclerosis

1 reference

12 December 2020

Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare

1 reference

12 December 2020

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

1 reference

12 December 2020

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type

1 reference

12 December 2020

Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis

1 reference

12 December 2020

A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort

1 reference

12 December 2020

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

1 reference

12 December 2020

Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.

1 reference

12 December 2020

Incomplete lupus erythematosus

1 reference

12 December 2020

Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.

1 reference

12 December 2020

Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients

1 reference

12 December 2020

C-reactive protein and serological indices of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

12 December 2020

Cytokines as biomarkers in rheumatoid arthritis

1 reference

12 December 2020

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

1 reference

12 December 2020

The Jo-1 antibody system in myositis: relationships to clinical features and HLA.

1 reference

12 December 2020

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

12 December 2020

Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases

1 reference

12 December 2020

Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis

1 reference

12 December 2020

Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy

1 reference

12 December 2020

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis

1 reference

12 December 2020

Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

1 reference

12 December 2020

Anti-PM-Scl antibody in patients with systemic sclerosis.

1 reference

12 December 2020

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis

1 reference

12 December 2020

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

1 reference

12 December 2020

Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity

1 reference

12 December 2020

Detection of lupus anticoagulant in patients attending an anticoagulation clinic

1 reference

12 December 2020

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

Molecular subsets in the gene expression signatures of scleroderma skin

1 reference

12 December 2020

High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus

1 reference

12 December 2020

Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

1 reference

12 December 2020

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.

1 reference

12 December 2020

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

1 reference

12 December 2020

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome

1 reference

12 December 2020

Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis.

1 reference

12 December 2020

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians

1 reference

12 December 2020

Anti-U3 RNP autoantibodies in systemic sclerosis

1 reference

12 December 2020

Autoantibody profiles in the sera of European patients with myositis

1 reference

12 December 2020

Predictive value of antibodies to citrullinated peptides and rheumatoid factors in anti-TNF-alpha treated patients

1 reference

12 December 2020

Polymyositis and dermatomyositis (first of two parts)

1 reference

12 December 2020

Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years

1 reference

12 December 2020

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

1 reference

12 December 2020

Autoantibody profiling to follow evolution of lupus syndromes

1 reference

12 December 2020

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis

1 reference

12 December 2020

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

1 reference

12 December 2020

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures

1 reference

12 December 2020

Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis

1 reference

12 December 2020

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

1 reference

12 December 2020

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

1 reference

12 December 2020

Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity

1 reference

12 December 2020

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

1 reference

12 December 2020

Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis

1 reference

12 December 2020

Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

1 reference

12 December 2020

The plasma cell signature in autoimmune disease

1 reference

12 December 2020

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

1 reference

12 December 2020

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis

1 reference

12 December 2020

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study

1 reference

12 December 2020

Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group

1 reference

12 December 2020

Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature

1 reference

12 December 2020

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis

1 reference

12 December 2020

Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

Changes in causes of death in systemic sclerosis, 1972-2002

1 reference

12 December 2020

The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis

1 reference

12 December 2020

Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis?

1 reference

12 December 2020

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

1 reference

12 December 2020

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

12 December 2020

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups

1 reference

12 December 2020

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

1 reference

12 December 2020

Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study

1 reference

12 December 2020

Polymyositis and dermatomyositis (second of two parts)

1 reference

12 December 2020

Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis

1 reference

12 December 2020

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.

1 reference

12 December 2020

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

1 reference

12 December 2020

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?

1 reference

12 December 2020

Systemic lupus erythematosus diagnostics in the 'omics' era

1 reference

12 December 2020

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

1 reference

12 December 2020

C-reactive protein in sera from patients with systemic lupus erythematosus

1 reference

12 December 2020

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

1 reference

12 December 2020

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.

1 reference

12 December 2020

The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009

1 reference

12 December 2020

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

1 reference

12 December 2020

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

1 reference

12 December 2020

Diagnosis of early rheumatoid arthritis: what the non-specialist needs to know

1 reference

12 December 2020

Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?

1 reference

12 December 2020

Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis

1 reference

12 December 2020

Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis

1 reference

12 December 2020

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.H5079

2 references

Consolidated OpenCitations Corpus – April 2017

2830764

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

release_mtztdt32pjfsbnjudymnnoiksu

13 May 2020

Fatcat ID

0 references

2830764

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6882504&resulttype=core&format=json

13 May 2020

PubMed publication ID

26612523

2 references

Consolidated OpenCitations Corpus – April 2017

2830764